Targeting an alternate Wilms’ tumor antigen 1 peptide bypasses immunoproteasome dependency
Article in Science Translational Medicine (February 2022)
The most recent citing publications are shown below. View all 14 publications that cite this research output on Dimensions.
CRISPR-based gene disruption and integration of high-avidity, WT1-specific T cell receptors improve antitumor T cell function
Article in Science Translational Medicine (February 2022)
Efficacy and safety of Wilms’ tumor 1 helper peptide OCV-501 in elderly patients with acute myeloid leukemia: a multicenter, randomized, double-blind, placebo-controlled phase 2 trial
Article in Cancer Immunology, Immunotherapy (October 2021)